ALLYSSA PLYMELL: Open Payments
NPI 1629469846 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 27 payments from 7 companies in 2025. Trend: 2023 $460 · 2024 $488 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $220 |
| Lilly USA, LLC | 5 | $93 |
| ABBVIE INC. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| Corcept Therapeutics | 2 | $29 |
| Madrigal Pharmaceuticals | 1 | $19 |
Products named: Wegovy, MOUNJARO, Ozempic, LINZESS, VOQUEZNA, JOURNAVX, Korlym, REZDIFFRA.
Industry payments across MO — which companies pay providers there.
